Seth Klarman’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Seth Klarman’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-53,331,109	Closed	-$1.27B	–	28
2014 Q2	$1.27B	Hold	53,331,109	–	–	20.67%	2
2014 Q1	$303M	Buy	53,331,109 +16,420,241	+44%	+$115M	7.32%	5
2013 Q4	$221M	Buy	36,910,868 +7,245,175	+24%	+$33.5M	6.25%	5
2013 Q3	$154M	Buy	29,665,693 +2,898,693	+11%	+$12.7M	4.4%	5
2013 Q2	$96.6M	Buy	+26,767,000	New	+$109M	2.4%	7

Seth Klarman's IDIX Position: Q3 2014 in Review

Seth Klarman sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 53,331,109 shares — an estimated $1.27B sold.

Seth Klarman first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $1.27B in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Seth Klarman reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Seth Klarman sold 53,331,109 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.27B.
Seth Klarman first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Seth Klarman's IDENIX PHARMACEUTICALS INC position peaked at $1.27B in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Baupost Group's 13F filing for Q3 2014, filed 14 Nov 2014.